7KM-23414-04717
2 vaccinations
5 coded responses
15 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 622 / IL
- Registered
- 2021-03-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Registered in v-safe
-
2021-03-04
Dose 1 — Pfizer-BioNTech
- 2021-03-04
- 2021-03-05
- 2021-03-08
- 2021-03-10
-
2021-03-18
Survey response — day 14, dose 1MedDRA: Neck pain, Rhinorrhoea — Feeling: FairFree text: Neck pain, runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-27
Dose 2 — Pfizer-BioNTech
- 2021-03-27
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-29
- 2021-03-30
- 2021-04-25
- 2021-05-01
-
2021-05-08
Survey response — day 42, dose 2MedDRA: Headache, Heart rate increased — Feeling: GoodFree text: Elevated heart rate and headachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-26
Survey response — 3 months, dose 2MedDRA: Heart rate increased, Hot flush, Menstruation irregular — Feeling: FairFree text: High heart rate, hot flashes, irregular periodMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-27
Survey response — 6 months, dose 2MedDRA: Graves' disease, Hyperthyroidism — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Hyperthyroidism, Graves diseaseMedDRA releases: 2024-11 · check-in free text available
-
2021-09-27
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-09-29
-
2021-09-29
Call successfulParticipant prefers to complete VAERS report online
-
2022-03-27
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous — Feeling: Good · Be unable to do your normal daily activitiesFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-03-27 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-27 | Successful 2021-09-29 |
Participant prefers to complete VAERS report online |
Free text
Release 5 — day 14, dose 1
Symptoms: Neck pain, runny nose
Release 8 — day 42, dose 2
Symptoms: Elevated heart rate and headaches
Release 9 — 3 months, dose 2
Symptoms: High heart rate, hot flashes, irregular period
Release 9 — 6 months, dose 2
Symptoms: Hyperthyroidism, Graves disease
Release 11 — 12 months, dose 2
Symptoms: Miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Graves' disease | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Heart rate increased | ✓ | ✓ | ✓ |
| SD | Hot flush | ✓ | ✓ | ✓ |
| SD | Hyperthyroidism | · | · | ✓ |
| SD | Menstruation irregular | ✓ | ✓ | ✓ |
| SD | Neck pain | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release